Home › Mantle Cell Lymphoma › California › San Francisco
Mantle Cell Lymphoma clinical trials in San Francisco, CA
4 studies for Mantle Cell Lymphoma are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
RecruitingPhase 2
- University of California, San Francisco, San Francisco
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- University of California, San Francisco, San Francisco
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
RecruitingPhase 1
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, San Francisco
Mantle Cell Lymphoma trials in other cities
- Baldwin Park, CA16 studies
- Houston, TX15 studies
- Seattle, WA13 studies
- Durham, NC13 studies
- Columbus, OH12 studies
- Milwaukee, WI12 studies
- New York City, NY12 studies
- Boston, MA11 studies
- Chicago, IL10 studies
- Nashville, TN10 studies
- Portland, OR9 studies
- Rochester, MN9 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer37 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer29 studies
- Lung Cancer23 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Colorectal Cancer19 studies
- Cardiovascular Disease18 studies
- Glioblastoma18 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.